Skip to content

Comparison of effects of levosimendan and dobutamine on the Prognosis in Patients with Septic Myocardial Contractility Impairment

Comparison of effects of levosimendan and dobutamine on the Prognosis in Patients with Septic Myocardial Contractility Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030126
Enrollment
Unknown
Registered
2020-02-23
Start date
2017-01-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Control:dobutamine
Intervention:levosimendan

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of septic shock conforms to the Chinese guidelines for the treatment of severe sepsis / septic shock (2014); 2. Echocardiography showed that the left ventricular ejection fraction (LVEF) was less than 50%; 3. Candidates are required to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. End stage renal failure (dependent on hemofiltration); 2. Severe chronic liver insufficiency; 3. Patients with a history of torsion at the tip; 4. Restrict the use of positive inotropic drugs (such as left ventricular outflow tract stenosis); 5. the use of levosimendan treatment within 30 days; 6. Acute myocardial infarction; 7. Patients with a history of chronic heart failure; 8. After cardiac surgery; 9. malignant arrhythmia; 10. Pericardial disease; 11. The patient does not want to be treated by levosimendan.

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Secondary

MeasureTime frame
OlO].The time of mechanical ventilation;Lactate;Length of stay in ICU;Cardiac Function;Liver and kidney function;

Countries

China

Contacts

Public ContactLi Li

Department of Intensive Care Medicine, Zhejiang Hospital

lilihbch@163.com+86 13666604253

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026